Enhancing immunotherapy for CLL patients with ibrutinib
Where will leukemia research go next?
ROR1 and its role in CLL and other cancers
The goals and work of the European Research Initiative on CLL (ERIC)
Benefits of deacetylase inhibitors for leukemia therapy